Bausch & Lomb/Immunetech Pharmaceuticals
Bausch & Lomb has obtained an exclusive U.S. and Canadian iicence for the ophthalmic indications of Immunetech's new Rx anti-allergy drug. Bausch & Lomb said the drug, which wili be included in eye drop solutions, will be used in the treatment of allergic, vernal and giant papiliary conjunctivitis . . . .
You may also be interested in...
Vacci Prep is first “supplement to establish a standard of care for consumers when preparing their immune system for vaccinations,” Dentovations says.
Effective medical device regulation supports both safety and innovation needs. This article assesses how well the US FDA and the Australian TGA achieve this balance.